Scilex Holding (SCLX) Short-term Investments (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Short-term Investments of $200000.0 for Q1 2026, down 96.77% on a QoQ basis from $6.2 million in Q4 2025.

Scilex Holding (SCLX) Short-term Investments (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Short-term Investments for 4 consecutive years, with $200000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Short-term Investments changed N/A year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $200000.0 (changed N/A YoY), while the FY2025 annual figure was $6.2 million, changed N/A from the prior year.
  • Short-term Investments came in at $200000.0 for Q1 2026 at Scilex Holding, down from $6.2 million in the prior quarter.
  • The five-year high for Short-term Investments was $141.7 million in Q2 2022, with the low at $34961.0 in Q3 2022.
  • Average Short-term Investments over 3 years is $57.7 million, with a median of $6.2 million recorded in 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Dec 31, 2025 6.20 Mn
Sep 30, 2022 34,961.00
Jun 30, 2022 141.69 Mn
Mar 31, 2022 140.45 Mn
Dec 31, 2021 139.41 Mn